DSIJ Mindshare

Ending marginally lower, Sensex was down 69.68 points or 0.11 per cent at the 60,836.41 level while Nifty was down 30.10 points or 0.17 per cent at the 18,052.70 level. Apart from bank, realty and FMCG all other indices ended the trading session in negative territory.  

Alembic Pharmaceuticals has recently informed the exchange that it has received final approval from US Food & Drug Administration (USFDA) for Mesalamine Extended-Release Capsules. 

Breaking the four-day gaining streak, the benchmark indices ended lower with Sensex being down by 215.26 points or 0.35 per cent at 60,906.09 level and Nifty declining 62.60 points or 0.34 per cent at the end of the trading session. Apart from metals and pharma, majority of sectoral indices saw selling during the trading session.

On Tuesday, bulls took charge and led Sensex to end 374.76 points or 0.62 per cent higher at 61,121.35 level and Nifty to end 133.20 points or 0.74 per cent up at 18,145.40 level.

The domestic equity indices cheered on Monday, ending decently higher and Nifty regaining its 18,000 mark.